Panelists discuss balancing clinical trial data with real-world patient factors when choosing between treatment options, emphasizing the importance of quality of life alongside cancer control in the ...

Panelists discuss how the EMERALD trial demonstrated elacestrant's efficacy in ESR1-mutated tumors, particularly in patients who had received CDK4/6 inhibitors for at least 12 months. This led to its ...

We nominate Jessica MacIntyre for the 2025 Extraordinary Healer Award for Oncology Nursing for her personal, local and ...

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop ...

Dr. Daniel J. Boffa discusses the link between smoking cessation and increase in survival for people who are active smokers and diagnosed with cancer.

Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma ...

Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk ...

After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or ...